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The prevalence of diabetes is on the increase worldwide, being one of the fastest
growing international health emergencies in the 21st century. Diabetes that is not well
managed can have significant impact on morbidity and mortality, including being a risk
factor for stroke, renal dysfunction, leg amputation, cardiovascular diseases, loss of vision,
and neuropathy. The economic costs of diabetes can also be quite profound through direct
medical costs to individuals, families and healthcare systems, and loss of work and wages.
Strategies for managing diabetes often include regular physical activity, smoking cessation,
maintaining health body weight, and healthy diet. In addition, nutritional interventions
in the management of diabetes may involve reduction of calories in diets, the use of diets
with low glycaemic index, and increasing the fibre content of diets.
The role of dietary fibre in health and diseases such as diabetes, cardiovascular disease,
colon cancer, and obesity has been the subject of significant interest. While it has been
revealed that dietary fibre plays a role in the pathogenesis of chronic diseases, an evolving
area of research and attention is its effect on gut microbiota and type 2 diabetes. There
is evidence that diets that are high in fat and low in fibre may promote gut microbiota
dysbiosis as a result of the loss of beneficial and protective microbes, while a high-fibre diet
could inhibit protein fermentation and promote gut microbial eubiosis. Dietary fibre has
been reported to be a major energy source for intestinal bacteria and thus can significantly
affect the diversity of gut microflora.
Therefore, the current editorial provides an overview of the articles published in
the Special Issue on recent advances in nutrition and diabetes. It focuses on the role
of diet in the pathophysiology and management of diabetes including its effect on gut
microbiota. In this regard, Ojo et al. [1] conducted a systematic review and meta-analysis of
randomised controlled trials and sought to evaluate the role of dietary fibre in modulating
gut microbiota dysbiosis in patients with type 2 diabetes. The authors relied on the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Electronic databases
including EBSCOHost with links to Health Sciences Research Databases, EMBASE, Google
Scholar, and reference lists of articles were searched for relevant studies.
Searches were conducted from date of commencement of the database to 5 August
2020, and these were based on the Population, Intervention, Comparator, Outcomes,
Studies (PICOS) framework [1].
There were nine studies which met the inclusion criteria and were selected for the
systematic review and meta-analysis. Four distinct areas were identified, namely, the
effect of dietary fibre on gut microbiota, the role of dietary fibre on short-chain fatty acids
(SCFAs), glycaemic control, and adverse events [1]. The authors found significant difference
(p < 0.01) in the relative abundance of Bifidobacterium with a mean difference of 0.72
(95% CI, 0.56, 0.89) total SCFAs (p = 0.02), with a standardised mean difference of 0.5
(95% CI, 0.08, 0.91) between the dietary fibre group compared with placebo. However,
there were no significant differences (p > 0.05) between the groups with respect to acetic
acid, propionic acid, and butyric acid [1].
Furthermore, there was significant improvement (p = 0.002) in glycated haemoglobin,
with a mean difference of −0.18 (95% CI, −0.29, −0.06) in the dietary fibre group compared
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with placebo, although differences between the two groups were not significant (p > 0.05)
in relation to fasting blood glucose and homeostatic model assessment of insulin resistance
(HOMA-IR) [1]. The two groups were not significantly different (p > 0.05) in the subjects
who reported adverse events.
The promotion of gut microbes which are SCFA producers in greater diversity
and abundance by dietary fibre may be responsible for the improvement in glycated
haemoglobin, which could be due in part to increased glucagon-like peptide-1 (GLP-
1) production. There is evidence that Bifidobacterium lactis could increase glycogen
synthesis, decrease expression of hepatic gluconeogenesis genes, improve translocation
of glucose transport-4, and promote glucose uptake [1]. Furthermore, the reduction
in body weight of participants in the intervention group compared with control is
another area of interest, as this may have contributed to the observed improvement in
glycated haemoglobin [1]. Ojo et al. [1] concluded that dietary fibre can significantly
improve (p < 0.05) the relative abundance of Bifidobacterium, total SCFAs, and glycated
haemoglobin. However, the authors observed that dietary fibre did not appear to have
significant effect (p > 0.05) on fasting blood glucose, HOMA-IR, acetic acid, propionic
acid, butyric acid, and adverse events.
In a review by Salaza et al. [2], it was noted that the dysfunction of the gut microbiota
is a contributory factor in the pathophysiology of diabetes. It was also reported that the
lipid products derived from the gut microbiota may interact with cells from the immune
system, and this may have immunomodulatory effect. In particular, microbiota dysbiosis
could cause increased production of lipopolysaccharides leading to damage to the intestinal
barrier [2]. The prevailing pro-inflammatory environment can lead to a state of insulin
resistance and hyperglycaemia [2]. In contrast, the production of SCFAs during eubiosis
is useful in maintaining the integrity of the intestinal barrier [2]. The authors suggested
that dysbiosis of the gut microbiota can be reversed through the modification of the eating
habits of patients or with the administration of prebiotics, probiotics, and symbiotics.
In a related study, Ren et al. [3] conducted a randomised controlled trial to determine
the effect of an almond-based low carbohydrate diet on depression and glycometabolism,
gut microbiota, and fasting GLP-1 in patients with type 2 diabetes. Forty-five participants
with type 2 diabetes who were recruited from the diabetes club and the Endocrine Division
of the First and Second Affiliated Hospital of Soochow University were randomly assigned
to a low-carbohydrate diet (LCD) or a low-fat diet (LFD) [3]. The dietary intervention
was for a period of 3 months, including 22 participants in the LCD group and 23 in the
LFD group. The measures of depression and biochemical parameters such as glycated
haemoglobin, gut microbiota, and GLP-1 concentration were assessed at baseline and post
intervention. The two groups were then compared. Ren et al. [3] found that LCD signif-
icantly improved depression and glycated haemoglobin (p < 0.01) and increased SCFAs
producing bacteria Roseburia, Ruminococcus, and Eubacterium. In addition, the GLP-1 con-
centration in the LCD group was higher than that in the LFD group (p < 0.05). The authors
concluded that LCD may provide beneficial effect on depression and glycometabolism in
patients with type 2 diabetes. It was further suggested that the role of LCD in improving
depression in patients with type 2 diabetes may be related to its role in stimulating the
growth of SCFAs-producing bacteria, increasing SCFA production and further maintaining
GLP-1 secretion [3].
McKenzie et al. [4] assessed the effect of type 2 diabetes prevention programme
aimed at reducing hyperglycaemia and normalising glycaemia in order to delay or prevent
the progression to type 2 diabetes. The study involved 96 patients with prediabetes
who received intervention involving carbohydrate restricted nutrition therapy for two
years that was delivered through remote care team. It was found that the estimated
cumulative incidence of normoglycemia and type 2 diabetes at two years were 52.3%
and 3%, respectively [4]. There was significant decrease in the prevalence of metabolic
syndrome, obesity, and suspected hepatic steatosis at two years [4].
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There is evidence that the inflammation due to gingivitis and/or periodontitis tends
to worsen during pregnancy due to hormonal changes, and these have implications for
maternal health beyond the oral cavity [5]. For example, this inflammation could lead to a
low-grade systemic inflammatory and metabolic disturbances which can have an impact on
pregnancy outcomes [5]. Therefore, there appears to be a relationship between periodontal
inflammation and diabetes, and thus managing inflammatory periodontal diseases may
improve glycaemic control and associated diabetic complications. In recognition of this,
Rodrigues Amorim Adegboye et al. [5] conducted a randomised controlled trial to explore
the effect of a non-pharmacological multi-component intervention on periodontal health
and metabolic and inflammatory profiles among pregnant women with periodontitis.
The study involved 69 pregnant women receiving prenatal care in a Brazilian public
health centre who were randomly allocated to four groups: (1) fortified sachet (vitamin D
and calcium) and powdered milk plus periodontal therapy during pregnancy (early PT),
(2) placebo sachet and powdered milk plus early PT, (3) fortified sachet and powdered
milk plus late PT (after delivery), and (4) placebo sachet and powdered milk plus late
PT [5]. The mean bleeding on probing (BOP) was significantly reduced in the early PT
groups, while BOP worsened in the late PT groups. No significant effect of fortification on
BOP was observed, and there were also no significant differences in the glucose levels and
birthweight among the groups [5].
The use of dietary interventions such as dietary fibre and low carbohydrate diet
in modulating gut microbiota dysbiosis, promoting SCFAs production and glycaemic
control in patients with type 2 diabetes is evident. However, as this is an evolving area
of research, more studies are needed to further understand the mechanism of the role
of diets on gut microbiota.
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